CStone Pharmaceuticals
CSPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$91 | -$367 | -$903 | -$1,920 |
| Dep. & Amort. | $50 | $58 | $45 | $23 |
| Deferred Tax | $0 | $0 | $0 | $134 |
| Stock-Based Comp. | -$3 | $37 | $142 | $223 |
| Change in WC | -$303 | -$140 | $73 | $65 |
| Other Non-Cash | $4 | -$177 | $31 | -$8 |
| Operating Cash Flow | -$343 | -$589 | -$612 | -$1,484 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$102 | -$149 |
| Net Acquisitions | $0 | $0 | $0 | -$48 |
| Inv. Purchases | -$255 | -$68 | -$683 | -$1,051 |
| Inv. Sales/Matur. | $1 | $515 | $1,147 | $364 |
| Other Inv. Act. | $6 | $172 | $3 | $58 |
| Investing Cash Flow | -$248 | $620 | $365 | -$827 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | $91 | $38 | $90 |
| Stock Issued | $0 | $342 | $3 | $17 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$12 | -$45 | -$12 | -$14 |
| Financing Cash Flow | -$13 | $388 | $28 | $92 |
| Forex Effect | -$5 | $19 | $35 | -$64 |
| Net Chg. in Cash | -$609 | $438 | -$184 | -$2,282 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $997 | $559 | $743 | $3,025 |
| End Cash | $388 | $997 | $559 | $743 |
| Free Cash Flow | -$343 | -$654 | -$714 | -$1,633 |